Moderna(Search results - 35)
World NewsAug 26, 2021, 5:34 PM IST
Japan suspends 1.63 million doses of Moderna vaccine after contamination found
Japan and Moderna both maintained that no safety or efficacy issues had been identified and further stated that the suspension was only a precaution.
United StatesAug 13, 2021, 11:50 AM IST
US authorises COVID booster jabs for those with weak immune systems to curb spread of Delta variant
As the country is struggling with the Delta variant, this authorization of emergency use for the third injection of Pfizer-BioNTech and Moderna vaccines, granted by the US Food and Drug Administration (FDA) regulator, came as a relief.
CoronavirusAug 12, 2021, 5:37 PM IST
Moderna 76%, Pfizer 42% effective against COVID-19 Delta variant: Mayo Clinic study
A Mayo Clinic study peered at the effectiveness of mRNA vaccines between January and July.
Top StoriesAug 7, 2021, 2:23 PM IST
Johnson & Johnson gets Emergency Use Approval for its single-dose COVID-19 vaccine in India
India has so far approved four vaccines - AstraZeneca's Covishield, Bharati Biotech's Covaxin, Russian Gamaleya Institute's Sputnik V and Moderna's vaccine.
United StatesAug 7, 2021, 11:48 AM IST
White House says 50 per cent of Americans fully vaccinated against COVID-19
As per the data, more than 165 million people have received either two Moderna or Pfizer doses or one Johnson & Johnson shot.
World NewsAug 6, 2021, 12:13 PM IST
COVID-19 shot 93 per cent effective six months after second dose, says Moderna
Its original clinical trial showed 94 per cent efficacy. However, the vaccine manufacturer company said that they expect the most talked about booster shots to be necessary.
EuropeAug 3, 2021, 1:01 PM IST
Germany to offer booster doses against COVID-19 starting in September
Confirming the discourse with the federal health minister Jens Spahn, the citizens will be inoculated with mRNA vaccines from Pfizer-BioNTecha in Moderna irrespective of the vaccinations they had originally been administered.
Top StoriesJul 1, 2021, 10:01 AM IST
India urges European Union to accept Covishield, Covaxin or face mandatory quarantine
The EU countries accept only the vaccines approved by the European Medicines Agency, which are Pfizer, Moderna, AstraZeneca, and Janssen. But Covishield, which is the Indian version of AstraZeneca, is yet to get their clearance.
Top StoriesJul 1, 2021, 9:53 AM IST
Zydus Cadila applies for emergency use authorisation of its COVID-19 vaccine
An approval for Zydus’ vaccine, ZyCoV-D, would make it the fifth vaccine authorized for use in India, after Moderna, AstraZeneca and partner Serum Institute of India’s Covishield, Bharat Biotech’s Covaxin and Sputnik V developed by Russia’s Gamaleya Institute.
Top StoriesJun 30, 2021, 4:53 PM IST
From Covishield to Covaxin, Sputnik V and Moderna vaccine: Know dosage limit, duration, efficacy and more
To expand its mass vaccination program, the Indian government has now given clearance to Moderna vaccine thus providing a wider option for the public to choose between four vaccines. Earlier Covishield, Covaxin and Sputnik V were administered among the Indian population to contain the spread of Covid, now the Moderna vaccine will be added to that list.
Top StoriesJun 29, 2021, 2:41 PM IST
Moderna vaccine likely to get DCGI’s nod soon, Cipla to import and market COVID jab
The Drug Controller General of India (DCGI) is likely to approve Moderna's Covid-19 vaccine for emergency use in those aged 18 and above.
Top StoriesJun 28, 2021, 6:00 PM IST
Serum Institute urges govt to take up inclusion of Covishield in EU’s Vaccination Passport
Only four vaccines -- Comirnaty of Pfizer/BioNTech, Moderna, Vaxzervria by AstraZeneca-Oxford and Johnson & Johnson’s Janssen -- have been approved by the European Medicines Agency.
Coronavirus WorldJun 27, 2021, 4:29 PM IST
FDA adds possible risk of heart inflammation to Moderna, Pfizer COVID-19 vaccines
Warning update follows an extensive review of information and discussion by CDC’s Advisory Committee.
Top StoriesMay 24, 2021, 4:12 PM IST
Pfizer, Moderna refused to sell COVID vaccines directly to us, they’ll only deal with Centre: Arvind Kejriwal
Vaccine rollout for the 18-44 age group was paused on Saturday in Delhi due to the shortage of doses.